19
Participants
Start Date
April 30, 2006
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
botulinum toxin A
Injection of BTXA into cervical and upper back muscles based on treatment plan prescribed for each participant individually based on muscle soreness and tightness. Injections occured on one single clinic visit.Both the saline and BTXA were dosed in 25 cc syringes and looked the same for the physician performing the injections to ensure both participant and study physician remained blinded.
placebo
Injection of normal saline into cervical and upper back muscles was also based on treatment plan prescribed for each participant individually based on muscle soreness and tightness. Injections occured on one single clinic visit. Both the saline and BTXA were dosed in 25 cc syringes and looked the same for the physician performing the injections to ensure both participant and study physician remained blinded.
Craig Hospital, Englewood
Collaborators (1)
The Craig H. Neilsen Foundation
OTHER
Allergan
INDUSTRY
Craig Hospital
OTHER